Hidetoshi Shiga

1.6k total citations
57 papers, 1.0k citations indexed

About

Hidetoshi Shiga is a scholar working on Nephrology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hidetoshi Shiga has authored 57 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Nephrology, 19 papers in Epidemiology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hidetoshi Shiga's work include Sepsis Diagnosis and Treatment (16 papers), Acute Kidney Injury Research (13 papers) and Dialysis and Renal Disease Management (11 papers). Hidetoshi Shiga is often cited by papers focused on Sepsis Diagnosis and Treatment (16 papers), Acute Kidney Injury Research (13 papers) and Dialysis and Renal Disease Management (11 papers). Hidetoshi Shiga collaborates with scholars based in Japan, Austria and United Kingdom. Hidetoshi Shiga's co-authors include Hiroyuki Hirasawa, Shigeto Oda, Kenichi Matsuda, Masataka Nakamura, Kazuya Nakanishi, Eizo Watanabe, Hideo Mori, Tomohito Sadahiro, Kenichi Matsuda and Takeshi Hirano and has published in prestigious journals such as Critical Care Medicine, Intensive Care Medicine and Dental Materials.

In The Last Decade

Hidetoshi Shiga

54 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hidetoshi Shiga Japan 18 404 269 269 266 252 57 1.0k
Kenichi Matsuda Japan 19 450 1.1× 301 1.1× 318 1.2× 326 1.2× 258 1.0× 74 1.2k
Federico Nalesso Italy 20 369 0.9× 451 1.7× 318 1.2× 256 1.0× 966 3.8× 115 1.8k
Naïke Bigé France 21 458 1.1× 308 1.1× 168 0.6× 190 0.7× 194 0.8× 67 1.1k
Khajohn Tiranathanagul Thailand 18 165 0.4× 271 1.0× 115 0.4× 116 0.4× 647 2.6× 70 1.1k
Ghodrat A. Siami United States 17 347 0.9× 94 0.3× 192 0.7× 163 0.6× 193 0.8× 29 1.1k
Vincenzo Malcangi Italy 5 421 1.0× 550 2.0× 208 0.8× 599 2.3× 279 1.1× 6 1.2k
Guillaume Louis France 18 307 0.8× 403 1.5× 207 0.8× 371 1.4× 59 0.2× 44 1.2k
Eric F.H. van Bommel Netherlands 23 434 1.1× 746 2.8× 116 0.4× 217 0.8× 606 2.4× 55 1.7k
Ahmed Mukhtar Egypt 21 226 0.6× 562 2.1× 250 0.9× 145 0.5× 101 0.4× 69 1.1k
M Coffernils Belgium 9 788 2.0× 712 2.6× 170 0.6× 347 1.3× 422 1.7× 15 1.5k

Countries citing papers authored by Hidetoshi Shiga

Since Specialization
Citations

This map shows the geographic impact of Hidetoshi Shiga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hidetoshi Shiga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hidetoshi Shiga more than expected).

Fields of papers citing papers by Hidetoshi Shiga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hidetoshi Shiga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hidetoshi Shiga. The network helps show where Hidetoshi Shiga may publish in the future.

Co-authorship network of co-authors of Hidetoshi Shiga

This figure shows the co-authorship network connecting the top 25 collaborators of Hidetoshi Shiga. A scholar is included among the top collaborators of Hidetoshi Shiga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hidetoshi Shiga. Hidetoshi Shiga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abe, Masanori, Hidetoshi Shiga, Hiroomi Tatsumi, et al.. (2022). Results of the 2018 Japan Society for Blood Purification in Critical Care survey: current status and outcomes. Renal Replacement Therapy. 8(1). 58–58. 7 indexed citations
2.
3.
Hirasawa, Hiroyuki, Takao Sugai, Shigeto Oda, et al.. (2015). Nafamostat Mesylate as Anticoagulant in Continuous Hemofiltration and Continuous Hemodiafiltration. Contributions to nephrology. 93. 215–217. 21 indexed citations
4.
Arata, Shinju, Toshiaki Ikeda, Kazui Soma, et al.. (2012). The safety and tolerance of enteral nutrition in severe acute pancreatitis: a multicenter prospective case series study. Nihon Kyukyu Igakukai Zasshi Journal of Japanese Association for Acute Medicine. 23(6). 233–241. 1 indexed citations
5.
Hirasawa, Hiroyuki, Shigeto Oda, Masataka Nakamura, et al.. (2012). Continuous Hemodiafiltration with a Cytokine-Adsorbing Hemofilter for Sepsis. Blood Purification. 34(2). 164–170. 47 indexed citations
6.
Shiga, Hidetoshi, et al.. (2010). Special Considerations in Continuous Hemodiafiltration with Critically Ill Pediatric Patients. Contributions to nephrology. 166. 158–166. 3 indexed citations
7.
Oda, Shigeto, Hidetoshi Shiga, Kenichi Matsuda, et al.. (2008). Efficacy of high-flow dialysate continuous hemodiafiltration in the treatment of fulminant hepatic failure. Transfusion and Apheresis Science. 40(1). 61–70. 27 indexed citations
8.
Nakada, Taka‐aki, Hiroyuki Hirasawa, Shigeto Oda, Hidetoshi Shiga, & Kenichi Matsuda. (2006). Blood purification for hypercytokinemia. Transfusion and Apheresis Science. 35(3). 253–264. 21 indexed citations
9.
Nakada, Taka‐aki, Hiroyuki Hirasawa, Shigeto Oda, et al.. (2005). Influence of Toll-Like Receptor 4, CD14, Tumor Necrosis Factor, and Interleukine-10 Gene Polymorphisms on Clinical Outcome in Japanese Critically Ill Patients. Journal of Surgical Research. 129(2). 322–328. 67 indexed citations
10.
Sugai, Takao, Hiroyuki Hirasawa, Shigeto Oda, et al.. (2005). Prediction of iopromide reduction rates during haemodialysis using an in vitro dialysis system. Nephrology Dialysis Transplantation. 20(4). 754–759. 3 indexed citations
11.
Oda, Shigeto, Hiroyuki Hirasawa, Hidetoshi Shiga, et al.. (2005). Management of Intra‐abdominal Hypertension in Patients With Severe Acute Pancreatitis With Continuous Hemodiafiltration Using a Polymethyl Methacrylate Membrane Hemofilter. Therapeutic Apheresis and Dialysis. 9(4). 355–361. 58 indexed citations
12.
Mori, Hideo, Hiroyuki Hirasawa, Shigeto Oda, et al.. (2005). Oral Care Reduces Incidence of Ventilator-Associated Pneumonia in ICU Populations. Intensive Care Medicine. 32(2). 230–236. 165 indexed citations
13.
Watanabe, Eizo, Hiroyuki Hirasawa, Shigeto Oda, et al.. (2005). Cytokine-Related Genotypic Differences in Peak Interleukin-6 Blood Levels of Patients with SIRS and Septic Complications. The Journal of Trauma: Injury, Infection, and Critical Care. 59(5). 1181–1190. 34 indexed citations
14.
Hirano, Takeshi, Hiroyuki Hirasawa, Shigeto Oda, et al.. (2004). Modulation of Polymorphonuclear Leukocyte Apoptosis in the Critically Ill by Removal of Cytokines with Continuous Hemodiafiltration. Blood Purification. 22(2). 188–197. 11 indexed citations
15.
Hirasawa, Hiroyuki, et al.. (2004). Partial liquid ventilation with FC-77 suppresses the release of lipid mediators in rat acute lung injury model. Critical Care Medicine. 32(10). 2085–2089. 8 indexed citations
16.
Moriguchi, Takeshi, Hiroyuki Hirasawa, Shigeto Oda, et al.. (2002). A Patient with Severe Acute Pancreatitis Successfully Treated with a New Critical Care Procedure. Therapeutic Apheresis. 6(3). 221–224. 11 indexed citations
17.
Hirasawa, Hiroyuki, et al.. (2002). Coagulation/fibrinolysis abnormality and vascular endothelial damage in the pathogenesis of thrombocytopenic multiple organ failure. Critical Care Medicine. 30(10). 2242–2248. 32 indexed citations
18.
Oda, Shigeto, Hiroyuki Hirasawa, Takao Sugai, et al.. (2000). Comparison of Sepsis-related Organ Failure Assessment (SOFA) score and CIS (cellular injury score) for scoring of severity for patients with multiple organ dysfunction syndrome (MODS). Intensive Care Medicine. 26(12). 1786–1793. 47 indexed citations
19.
Oda, Shigeto, et al.. (1998). Cellular Injury Score for Multiple Organ Failure Severity Scoring System. PubMed. 45(2). 304–311. 23 indexed citations
20.
Hirasawa, Hiroyuki, Takao Sugai, Shigeto Oda, et al.. (1997). Efficacy and Limitation of Apheresis Therapy in Critical Care. Therapeutic Apheresis. 1(3). 228–232. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenichi Matsuda Breakdown of academic impact, for papers by Federico Nalesso Breakdown of academic impact, for papers by Naïke Bigé Breakdown of academic impact, for papers by Khajohn Tiranathanagul Breakdown of academic impact, for papers by Ghodrat A. Siami Breakdown of academic impact, for papers by Vincenzo Malcangi Breakdown of academic impact, for papers by Guillaume Louis Breakdown of academic impact, for papers by Eric F.H. van Bommel Breakdown of academic impact, for papers by Ahmed Mukhtar Breakdown of academic impact, for papers by M Coffernils
Rankless by CCL
2026